awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37670707-66F13870-E2A7-49A8-AC33-F4F1D33C918D
Q37670707-66F13870-E2A7-49A8-AC33-F4F1D33C918D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37670707-66F13870-E2A7-49A8-AC33-F4F1D33C918D
Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?
P2860
Q37670707-66F13870-E2A7-49A8-AC33-F4F1D33C918D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37670707-66F13870-E2A7-49A8-AC33-F4F1D33C918D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b11b076e9e6be1bbad73c62884b206f121433e57
P2860
A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression.